{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:43:36Z","timestamp":1743727416614},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:00:00Z","timestamp":1314057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10157-011-0522-1","type":"journal-article","created":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T00:45:28Z","timestamp":1313973928000},"page":"854-860","source":"Crossref","is-referenced-by-count":6,"title":["Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Tomonori","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritaka","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Shinzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hamono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"key":"522_CR1","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154\u201369.","journal-title":"Circulation"},{"key":"522_CR2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"522_CR3","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/ndt\/gfn181","volume":"23","author":"T Hayashi","year":"2008","unstructured":"Hayashi T, Obi Y, Kimura T, Iio KI, Sumitsuji S, Takeda Y, et al. Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy. Nephrol Dial Transpl. 2008;23:2936\u201342.","journal-title":"Nephrol Dial Transpl"},{"key":"522_CR4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ndt\/12.4.718","volume":"12","author":"N Joki","year":"1997","unstructured":"Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transpl. 1997;12:718\u201323.","journal-title":"Nephrol Dial Transpl"},{"key":"522_CR5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","volume":"106","author":"J Al Suwaidi","year":"2002","unstructured":"Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974\u201380.","journal-title":"Circulation"},{"key":"522_CR6","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","volume":"108","author":"HM Sadeghi","year":"2003","unstructured":"Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769\u201375.","journal-title":"Circulation"},{"issue":"2","key":"522_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(02)70081-4","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2):S1\u2013266.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"522_CR8","first-page":"S1","volume":"47","author":"National Kidney Foundation","year":"2006","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(5):S1\u2013149.","journal-title":"Am J Kidney Dis"},{"key":"522_CR9","doi-asserted-by":"crossref","unstructured":"Kimura T, Obi Y, Yasuda K, Sasaki KI, Takeda Y, Nagai Y, et al. Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography. Nephrol Dial Transplant. 2010.","DOI":"10.1093\/ndt\/gfq631"},{"key":"522_CR10","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2215\/CJN.08061109","volume":"5","author":"Y Obi","year":"2010","unstructured":"Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol. 2010;5:1558\u201365.","journal-title":"Clin J Am Soc Nephrol"},{"key":"522_CR11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","volume":"12","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001;12:1508\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"522_CR12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.ki.5001558","volume":"70","author":"C Zoccali","year":"2006","unstructured":"Zoccali C, Mallamaci F. A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients? Kidney Int. 2006;70:408\u201310.","journal-title":"Kidney Int"},{"key":"522_CR13","first-page":"1007","volume":"52","author":"K Yasuda","year":"2010","unstructured":"Yasuda K, Kimura T, Obi Y, Sasaki K, Hatanaka M, Isaka Y, et al. Plasma B-type natriuretic peptide level predicts the renal outcome in patients with chronic kidney disease. Nippon Jinzo Gakkai Shi. 2010;52:1007\u201314.","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"522_CR14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.ajkd.2006.01.027","volume":"47","author":"Y Ohya","year":"2006","unstructured":"Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis. 2006;47:790\u20137.","journal-title":"Am J Kidney Dis"},{"key":"522_CR15","doi-asserted-by":"crossref","unstructured":"Andrade J, Er L, Ignaszewski A, Levin A. Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness. Clin J Am Soc Nephrol. 2008.","DOI":"10.2215\/CJN.00900208"},{"key":"522_CR16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jash.2010.03.008","volume":"4","author":"SM Hogas","year":"2010","unstructured":"Hogas SM, Voroneanu L, Serban DN, Segall L, Hogas MM, Serban IL, et al. Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach. J Am Soc Hypertens. 2010;4:116\u201327.","journal-title":"J Am Soc Hypertens"},{"key":"522_CR17","doi-asserted-by":"crossref","first-page":"18J","DOI":"10.1016\/0002-9149(89)90200-2","volume":"63","author":"N Taira","year":"1989","unstructured":"Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J\u201324J.","journal-title":"Am J Cardiol"},{"key":"522_CR18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00005344-199104000-00016","volume":"17","author":"WR Kukovetz","year":"1991","unstructured":"Kukovetz WR, Holzmann S, Braida C, Poch G. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J Cardiovasc Pharmacol. 1991;17:627\u201333.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","volume":"359","author":"IONA Study Group","year":"2002","unstructured":"IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269\u201375.","journal-title":"Lancet"},{"key":"522_CR20","doi-asserted-by":"crossref","unstructured":"Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Imai R, et al. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2009.","DOI":"10.1053\/j.ajkd.2009.03.025"},{"key":"522_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.fjc.0000162771.00174.a8","volume":"46","author":"M Sekiya","year":"2005","unstructured":"Sekiya M, Sato M, Funada J, Ohtani T, Akutsu H, Watanabe K. Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. J Cardiovasc Pharmacol. 2005;46:63\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FJC.0b013e318163a95f","volume":"51","author":"Y Ishibashi","year":"2008","unstructured":"Ishibashi Y, Takahashi N, Tokumaru A, Karino K, Sugamori T, Sakane T, et al. Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease. J Cardiovasc Pharmacol. 2008;51:311\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/hc0302.102572","volume":"105","author":"TM Lee","year":"2002","unstructured":"Lee TM, Su SF, Chou TF, Lee YT, Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation. 2002;105:334\u201340.","journal-title":"Circulation"},{"key":"522_CR24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"522_CR25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjhyper.2006.09.019","volume":"20","author":"J Hashimoto","year":"2007","unstructured":"Hashimoto J, Imai Y, O\u2019Rourke MF. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens. 2007;20:378\u201384.","journal-title":"Am J Hypertens"},{"key":"522_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1291\/hypres.30.219","volume":"30","author":"K Takazawa","year":"2007","unstructured":"Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res. 2007;30:219\u201328.","journal-title":"Hypertens Res"},{"key":"522_CR27","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","volume":"41","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003;41:1761\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"522_CR28","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","volume":"44","author":"PO Bonetti","year":"2004","unstructured":"Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"522_CR29","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2009.10.073","volume":"55","author":"Y Matsuzawa","year":"2010","unstructured":"Matsuzawa Y, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Konishi M, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol. 2010;55:1688\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"522_CR30","doi-asserted-by":"crossref","unstructured":"Tagore R, Ling LH, Yang H, Daw HY, Chan YH, Sethi SK. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol. 2008.","DOI":"10.2215\/CJN.00850208"},{"key":"522_CR31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","volume":"46","author":"S Vickery","year":"2005","unstructured":"Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis. 2005;46:610\u201320.","journal-title":"Am J Kidney Dis"},{"key":"522_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejheart.2004.01.004","volume":"6","author":"M Vanderheyden","year":"2004","unstructured":"Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail. 2004;6:261\u20138.","journal-title":"Eur J Heart Fail"},{"key":"522_CR33","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00259.2002","volume":"285","author":"DL Vesely","year":"2003","unstructured":"Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol. 2003;285:F167\u201377.","journal-title":"Am J Physiol Renal Physiol"},{"key":"522_CR34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.110.156547","volume":"56","author":"MT Maeder","year":"2010","unstructured":"Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension. 2010;56:682\u20139.","journal-title":"Hypertension"},{"key":"522_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jacc.2009.04.068","volume":"54","author":"M Cecelja","year":"2009","unstructured":"Cecelja M, Jiang B, McNeill K, Kato B, Ritter J, Spector T, et al. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. J Am Coll Cardiol. 2009;54:695\u2013703.","journal-title":"J Am Coll Cardiol"},{"key":"522_CR36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.fjc.0000184466.37951.76","volume":"46","author":"T Date","year":"2005","unstructured":"Date T, Taniguchi I, Inada K, Matsuo S, Miyanaga S, Yamane T, et al. Nicorandil inhibits serum starvation-induced apoptosis in vascular endothelial cells. J Cardiovasc Pharmacol. 2005;46:721\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.fjc.0000176728.74690.09","volume":"46","author":"M Hongo","year":"2005","unstructured":"Hongo M, Mawatari E, Sakai A, Ruan Z, Koizumi T, Terasawa F, et al. Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats. J Cardiovasc Pharmacol. 2005;46:452\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00005344-200108000-00005","volume":"38","author":"S Horinaka","year":"2001","unstructured":"Horinaka S, Kobayashi N, Higashi T, Hara K, Hara S, Matsuoka H. Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat. J Cardiovasc Pharmacol. 2001;38:200\u201310.","journal-title":"J Cardiovasc Pharmacol"},{"key":"522_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(03)03383-3","volume":"990","author":"Y Teshima","year":"2003","unstructured":"Teshima Y, Akao M, Baumgartner WA, Marban E. Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels. Brain Res. 2003;990:45\u201350.","journal-title":"Brain Res"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0522-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-011-0522-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0522-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T05:56:52Z","timestamp":1638338212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-011-0522-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,23]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1007\/s10157-011-0522-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,23]]}}}